In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell Lines

Gastric cancer exhibits a poor prognosis and is the third most common cause of cancer death worldwide. Chemotherapy of metastatic gastric cancer is based on combinations of platinum drugs and fluoropyrimidines, with added agents. Oxoplatin is a stable oral platinum(IV) prodrug which is converted to...

Descripción completa

Detalles Bibliográficos
Autores principales: Klameth, Lukas, Rath, Barbara, Hamilton, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556635/
https://www.ncbi.nlm.nih.gov/pubmed/28819369
http://dx.doi.org/10.7150/jca.17816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556635/
https://www.ncbi.nlm.nih.gov/pubmed/28819369
http://dx.doi.org/10.7150/jca.17816

Ejemplares similares